Kakao Ventures' Seven Portfolio Companies Head to CES 2026; NeuroTX Wins Innovation Award

The global stage for innovation, CES 2026, will be held in Las Vegas, USA, from January 6 to 9 next year (local time) under the slogan 'Innovators Show Up.' Seven innovative startups invested in by Kakao Ventures will participate, showcasing their technological capabilities on the world stage. The companies participating in CES 2026 are distinguishing themselves in cutting-edge technology fields such as AI, digital health, extended reality (XR), and manufacturing automation. Notably, NeuroTX, which develops a sleep disorder solution combining AI and neurostimulation technology, is already drawing attention after winning an Innovation Award in the Digital Health category. Their innovative product, 'WillSleep,' is slated for release in the first quarter of 2026. A Kakao Ventures official stated, "The participating companies are teams that have built unique technological competitiveness applicable across a wide range of areas, from daily life to industrial sites." They added, "We expect their participation in CES 2026 to be an important opportunity to discover business opportunities in the global market and expand worldwide." The participating companies present the future with the following innovative technologies. * NeuroTX: Develops 'WillSleep,' a solution to resolve sleep disorders using AI-based neurostimulation technology. (Winner of a CES 2026 Innovation Award in the Digital Health category) * Retinal: An ultra-lightweight optical module for AR glasses utilizing 'Pin Mirror' technology, improving the bulkiness and image quality limitations of AR glasses. * Recon Labs: Provides 'Zenpresso,' a node-based solution for integrated production of images, videos, and 3D content, with an AI agent assisting the design process. * LumenLab: Offers an AI-based parenting platform 'Winit,' providing child growth record management, development information, and AI video content creation features. * Omlet: Solves optimization problems in logistics, robotics, and transportation industries with a generative AI-based combinatorial optimization algorithm, operating 'OASIS,' logistics delivery optimization software. * Confortlab: Implements equipment data integration, AI-based quality tracking, and equipment maintenance functions with 'PORTA,' a no-code platform providing manufacturing data-based operational management automation solutions. * Portrai: A tech-bio company developing new drug discovery solutions using AI-based spatial transcriptomics technology, focusing on predicting cancer cells through RNA spatial data analysis and developing new drugs for solid cancers like lung cancer, currently conducting joint research with Celltrion and others. These companies are expected to present innovative technologies and products in their respective specialized fields, attracting the attention of the global market.